158 related articles for article (PubMed ID: 30076960)
1. A novel porcupine inhibitor blocks WNT pathways and attenuates cardiac hypertrophy.
Jiang J; Lan C; Li L; Yang D; Xia X; Liao Q; Fu W; Chen X; An S; Wang WE; Zeng C
Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3459-3467. PubMed ID: 30076960
[TBL] [Abstract][Full Text] [Related]
2. Porcupine inhibitor CGX1321 alleviates heart failure with preserved ejection fraction in mice by blocking WNT signaling.
Wu H; Tang LX; Wang XM; Li LP; Chen XK; He YJ; Yang DZ; Shi Y; Shou JL; Zhang ZS; Wang L; Lu BJ; An SM; Zeng CY; Wang WE
Acta Pharmacol Sin; 2023 Jun; 44(6):1149-1160. PubMed ID: 36473990
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic effect of a novel Wnt pathway inhibitor on cardiac regeneration after myocardial infarction.
Yang D; Fu W; Li L; Xia X; Liao Q; Yue R; Chen H; Chen X; An S; Zeng C; Wang WE
Clin Sci (Lond); 2017 Dec; 131(24):2919-2932. PubMed ID: 29162747
[TBL] [Abstract][Full Text] [Related]
4. Wnt-C59 Attenuates Pressure Overload-Induced Cardiac Hypertrophy via Interruption of Wnt Pathway.
Zhao Z; Liu H; Li Y; Tian J; Deng S
Med Sci Monit; 2020 Apr; 26():e923025. PubMed ID: 32279067
[TBL] [Abstract][Full Text] [Related]
5. Polyphyllin I attenuates pressure over-load induced cardiac hypertrophy via inhibition of Wnt/β-catenin signaling pathway.
Li Q; Jiang W; Wan Z; Ni Y; Lei L; Wei J
Life Sci; 2020 Jul; 252():117624. PubMed ID: 32259602
[TBL] [Abstract][Full Text] [Related]
6. Porcupine inhibitors: Novel and emerging anti-cancer therapeutics targeting the Wnt signaling pathway.
Shah K; Panchal S; Patel B
Pharmacol Res; 2021 May; 167():105532. PubMed ID: 33677106
[TBL] [Abstract][Full Text] [Related]
7. Experimental inhibition of porcupine-mediated Wnt O-acylation attenuates kidney fibrosis.
Madan B; Patel MB; Zhang J; Bunte RM; Rudemiller NP; Griffiths R; Virshup DM; Crowley SD
Kidney Int; 2016 May; 89(5):1062-1074. PubMed ID: 27083283
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol as a new inhibitor of immunoproteasome prevents PTEN degradation and attenuates cardiac hypertrophy after pressure overload.
Chen C; Zou LX; Lin QY; Yan X; Bi HL; Xie X; Wang S; Wang QS; Zhang YL; Li HH
Redox Biol; 2019 Jan; 20():390-401. PubMed ID: 30412827
[TBL] [Abstract][Full Text] [Related]
9. Attenuation of microRNA-16 derepresses the cyclins D1, D2 and E1 to provoke cardiomyocyte hypertrophy.
Huang S; Zou X; Zhu JN; Fu YH; Lin QX; Liang YY; Deng CY; Kuang SJ; Zhang MZ; Liao YL; Zheng XL; Yu XY; Shan ZX
J Cell Mol Med; 2015 Mar; 19(3):608-19. PubMed ID: 25583328
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the canonical Wnt signaling pathway by a β-catenin/CBP inhibitor prevents heart failure by ameliorating cardiac hypertrophy and fibrosis.
Methatham T; Tomida S; Kimura N; Imai Y; Aizawa K
Sci Rep; 2021 Jul; 11(1):14886. PubMed ID: 34290289
[TBL] [Abstract][Full Text] [Related]
11. Wnt/β-catenin signaling mediates both heart and kidney injury in type 2 cardiorenal syndrome.
Zhao Y; Wang C; Hong X; Miao J; Liao Y; Hou FF; Zhou L; Liu Y
Kidney Int; 2019 Apr; 95(4):815-829. PubMed ID: 30770217
[TBL] [Abstract][Full Text] [Related]
12. Sfrp1 attenuates TAC-induced cardiac dysfunction by inhibiting Wnt signaling pathway- mediated myocardial apoptosis in mice.
Pan S; Zhao X; Wang X; Tian X; Wang Y; Fan R; Feng N; Zhang S; Gu X; Jia M; Li J; Yang L; Wang K; Guo H; Pei J
Lipids Health Dis; 2018 Aug; 17(1):202. PubMed ID: 30153824
[TBL] [Abstract][Full Text] [Related]
13. Aldehyde dehydrogenase 2 deficiency blunts compensatory cardiac hypertrophy through modulating Akt phosphorylation early after transverse aorta constriction in mice.
Xia G; Fan F; Liu M; Wang S; Wu J; Shen C; Han S; Wang C; Jia J; Zou Y; Hu K; Ge J; Sun A
Biochim Biophys Acta; 2016 Sep; 1862(9):1587-93. PubMed ID: 27239698
[TBL] [Abstract][Full Text] [Related]
14. Ablation of biglycan attenuates cardiac hypertrophy and fibrosis after left ventricular pressure overload.
Beetz N; Rommel C; Schnick T; Neumann E; Lother A; Monroy-Ordonez EB; Zeeb M; Preissl S; Gilsbach R; Melchior-Becker A; Rylski B; Stoll M; Schaefer L; Beyersdorf F; Stiller B; Hein L
J Mol Cell Cardiol; 2016 Dec; 101():145-155. PubMed ID: 27789290
[TBL] [Abstract][Full Text] [Related]
15. Interruption of Wnt signaling attenuates the onset of pressure overload-induced cardiac hypertrophy.
van de Schans VA; van den Borne SW; Strzelecka AE; Janssen BJ; van der Velden JL; Langen RC; Wynshaw-Boris A; Smits JF; Blankesteijn WM
Hypertension; 2007 Mar; 49(3):473-80. PubMed ID: 17210832
[TBL] [Abstract][Full Text] [Related]
16. Secreted frizzled-related protein 2 prevents pressure-overload-induced cardiac hypertrophy by targeting the Wnt/β-catenin pathway.
Wei WY; Zhao Q; Zhang WZ; Wang MJ; Li Y; Wang SZ; Zhang N
Mol Cell Biochem; 2020 Sep; 472(1-2):241-251. PubMed ID: 32632611
[TBL] [Abstract][Full Text] [Related]
17. Cardiomyocyte specific overexpression of a 37 amino acid domain of regulator of G protein signalling 2 inhibits cardiac hypertrophy and improves function in response to pressure overload in mice.
Lee KN; Lu X; Nguyen C; Feng Q; Chidiac P
J Mol Cell Cardiol; 2017 Jul; 108():194-202. PubMed ID: 28641980
[TBL] [Abstract][Full Text] [Related]
18. Dapper-1 is essential for Wnt5a induced cardiomyocyte hypertrophy by regulating the Wnt/PCP pathway.
Hagenmueller M; Riffel JH; Bernhold E; Fan J; Katus HA; Hardt SE
FEBS Lett; 2014 Jun; 588(14):2230-7. PubMed ID: 24879894
[TBL] [Abstract][Full Text] [Related]
19. Klotho inhibits angiotensin II-induced cardiomyocyte hypertrophy through suppression of the AT1R/beta catenin pathway.
Yu L; Meng W; Ding J; Cheng M
Biochem Biophys Res Commun; 2016 Apr; 473(2):455-61. PubMed ID: 26970306
[TBL] [Abstract][Full Text] [Related]
20. Loss of Porcupine impairs convergent extension during gastrulation in zebrafish.
Chen Q; Takada R; Takada S
J Cell Sci; 2012 May; 125(Pt 9):2224-34. PubMed ID: 22357957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
